Educational Intervention With or Without Telephone Counseling in Increasing Colorectal Cancer Screening Compliance in Brothers and Sisters of Patients With Colorectal Cancer
Colorectal Cancer Screening Intervention for Family Members of Colorectal Cancer Patients
3 other identifiers
interventional
660
1 country
18
Brief Summary
RATIONALE: Printed educational materials and counseling by telephone may improve colorectal cancer screening compliance in brothers and sisters of patients with colorectal cancer. PURPOSE: This randomized phase III trial is studying standard or personalized printed educational materials with or without telephone counseling to compare how well they work in increasing colorectal cancer screening compliance in brothers and sisters of patients with colorectal cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_3 colorectal-cancer
Started Aug 2005
Typical duration for phase_3 colorectal-cancer
18 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2005
CompletedFirst Submitted
Initial submission to the registry
July 13, 2006
CompletedFirst Posted
Study publicly available on registry
July 14, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2013
CompletedMay 16, 2014
May 1, 2014
6.5 years
July 13, 2006
May 15, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Colorectal cancer screening compliance
Secondary Outcomes (3)
Impact on movement in stage of adoption
Increased knowledge and attitudes
Cost
Interventions
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
- Fox Chase Cancer Centerlead
- National Cancer Institute (NCI)collaborator
Study Sites (18)
Helen F. Graham Cancer Center at Christiana Care
Newark, Delaware, 19713, United States
Lombardi Comprehensive Cancer Center at Georgetown University Medical Center
Washington D.C., District of Columbia, 20007, United States
H. Lee Moffitt Cancer Center CCOP Research Base
Tampa, Florida, 33612, United States
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, 02114, United States
Hunterdon Regional Cancer Center at Hunterdon Medical Center
Flemington, New Jersey, 08822, United States
Fox Chase Virtua Health Cancer Program at Virtua Memorial Hospital Marlton
Marlton, New Jersey, 08053, United States
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
New Brunswick, New Jersey, 08903, United States
Franklin & Edith Scarpa Regional Cancer Center at South Jersey Healthcare
Vineland, New Jersey, 08360, United States
Memorial Sloan-Kettering Cancer Center
New York, New York, 10021, United States
PinnacleHealth Regional Cancer Center at Polyclinic Hospital
Harrisburg, Pennsylvania, 17105-8700, United States
St. Mary Regional Cancer Center
Langhorne, Pennsylvania, 19047, United States
Presbyterian Medical Center
Philadelphia, Pennsylvania, 19104, United States
Fox Chase Cancer Center - Philadelphia
Philadelphia, Pennsylvania, 19111-2497, United States
Fox Chase Cancer Center CCOP Research Base
Philadelphia, Pennsylvania, 19140, United States
Pottstown Memorial Regional Cancer Center
Pottstown, Pennsylvania, 19464, United States
McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
Reading, Pennsylvania, 19612-6052, United States
Northeast Regional Cancer Institute
Scranton, Pennsylvania, 18510, United States
M.D. Anderson Cancer Center at University of Texas
Houston, Texas, 77030-4009, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sharon Manne, PhD
Fox Chase Cancer Center
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 13, 2006
First Posted
July 14, 2006
Study Start
August 1, 2005
Primary Completion
February 1, 2012
Study Completion
November 1, 2013
Last Updated
May 16, 2014
Record last verified: 2014-05